De novo CSDE1 missense variant T595N regulates miRNA expression in a patient with a complex neurodevelopmental condition
Loss of function variants in CSDE1 have been identified in patients with neurodevelopmental disorders. De novo CSDE1 missense variant T595N was identified in an individual manifesting autistic behavior in addition to features typical of Cohen syndrome. Patient derived skin fibroblasts expressing T595N showed increased expression of HECW2. HECW2 is a ubiquitin ligase associated with neurodevelopment, and a synapse-related target of CSDE1. The E3 ligase activity of HECW2 is necessary for the downregulation of Dicer protein, a core component in the miRNA pathway that dictates miRNA expression.
Authors
- Eirik Frengen (ORCID: https://orcid.org/0000-0002-8387-2247)
- Petter Strømme (ORCID: https://orcid.org/0000-0003-3421-8131)
- Pavan Kumar Kakumani (ORCID: https://orcid.org/0000-0002-8755-860X)
- Doriana Misceo (ORCID: https://orcid.org/0000-0002-6594-5801)
- Evan G. Williams (ORCID: https://orcid.org/0000-0002-9746-376X)
- Claire Hynes
Institutions
- Oslo University Hospital (NO)
- Memorial University of Newfoundland (CA)
Publication Details
- Journal
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1016/j.bbadis.2025.168104
- Citations
- 1
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.82